Bill C-13, the COVID-19 Emergency Response Act, was the Canadian government’s legislative response to the Coronavirus pandemic. In addition a host of economic measures, the bill included some unexpected patent law provisions designed to speed access to essential medicines, devices or treatments. Matthew Herder, the director of the Health Law Institute at Dalhousie University, joins the podcast discuss the new Canadian rules, the use of compulsory licensing to enhance access to medicines, and other innovative approaches to overcoming potential access barriers raised by intellectual property laws.
Recent Posts
The Most Unworkable Internet Law in the World: Quebec Opens the Door to Mandating Minimum French Content Quotas for User Generated Content on Social Media 
CRTC Says No Regulatory Action Planned Against Meta For Blocking News Links 
The Law Bytes Podcast, Episode 252: Len St-Aubin on the CRTC’s Plan To Modernize Canadian Content Rules 
Why Freedom of Expression Must Not Become a Right to Harass or Intimidate 
The Law Bytes Podcast, Episode 251: Jennifer Pybus on the Debate Over Canadian Digital Sovereignty
